Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00582231 · ClinicalTrials.gov registry record

Penile Injection Anxiety

A clinical trial of Erectile Dysfunction and Penile Injection Therapy, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
126
Enrollment target
1
Study location

NCT00582231: Active study of Erectile Dysfunction and Penile Injection Therapy, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00582231 is a study of Erectile Dysfunction and Penile Injection Therapy that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 126 participants, below the 228-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00582231, a study of Erectile Dysfunction and Penile Injection Therapy, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
126 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to help us understand more about your experience with penile injection therapy. Many men become anxious when thinking about penile injections. We would like to understand more about this anxiety. You will be asked to fill out questionnaires before you start penile injection training, at each training visit, and then at your four month follow-up visit.

Interventions

  • OTHER Questionnaires.

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2007-02
Est. Completion 2026-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT00582231 still lists

NCT00582231 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 228-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (45% lower).

The record links to 3 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires. is the first listed.

NCT00582231 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00582231 about?

NCT00582231 is a clinical study titled "Penile Injection Anxiety". The purpose of this study is to help us understand more about your experience with penile injection therapy. Many men become anxious when thinking about penile injections. We would like to understand more about this anxiety. You will be asked to fill out questionnaires before you start penile inject...

What is the current status of trial NCT00582231?

This trial is currently active not recruiting. The enrollment target is 126 participants. The study started on 2007-02. Estimated completion is 2026-12.

What conditions does trial NCT00582231 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Penile Injection Therapy, Radical Pelvic Surgery.

What interventions are being tested in trial NCT00582231?

The interventions under investigation include: Questionnaires. (OTHER).

Who is sponsoring clinical trial NCT00582231?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00582231 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00582231's enrollment target sits among peer trials

126 14th of 33 higher than 20 of 33 other Erectile Dysfunction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00582231, the US trial registry maintained by the National Library of Medicine. NCT00582231 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.